TAPAS: Testing Adaptive Physical Activity in Stroke

Sponsor
Baltimore VA Medical Center (U.S. Fed)
Overall Status
Unknown status
CT.gov ID
NCT01042990
Collaborator
University of Maryland (Other)
54
1
3
36
1.5

Study Details

Study Description

Brief Summary

"Testing Adaptive Physical Activity in Stroke" tests the idea that adaptive physical activity (APA) will improve fitness, balance and walking function, daily step activity, and outcomes related to quality of life in individuals with chronic stroke. Adaptive physical activity is an exercise model that combines aerobic exercise with balance and gait training in a socially reinforcing group setting. Individualized homework assignments encourage integration of exercise into daily life routines. Our specific aims are:

  1. to determine whether APA improves cardiovascular fitness and metabolic health

  2. to measure the effects of APA on gait and balance, ambulatory activity, and ADL function

  3. to determine whether APA affects self-reported outcomes related to self-efficacy, fatigue, and stroke-specific quality of life

Condition or Disease Intervention/Treatment Phase
  • Other: Adaptive Physical Activity
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Testing Adaptive Physical Activity in Stroke
Study Start Date :
Sep 1, 2008
Anticipated Primary Completion Date :
Sep 1, 2011
Anticipated Study Completion Date :
Sep 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Home Exercise Only

Participants receive education and instruction on a home exercise program which they do on their own, with intermittent encouragement from study personnel.

Other: Adaptive Physical Activity
Structured gait, balance, and progressive walking program performed in a group gym setting 3x/week for 6 months

Experimental: APA

Participants exercise in a gym setting 3x/week for six months, performing gait and balance exercises along with a progressive walking program.

Other: Adaptive Physical Activity
Structured gait, balance, and progressive walking program performed in a group gym setting 3x/week for 6 months

Experimental: APA+TM

Participants exercise in a gym setting 3x/week for six months, performing a combined program of adaptive physical activity (gait and balance training) and progressive treadmill walking.

Other: Adaptive Physical Activity
Structured gait, balance, and progressive walking program performed in a group gym setting 3x/week for 6 months

Outcome Measures

Primary Outcome Measures

  1. VO2 Peak [baseline, 3 months, 6 months, and 3 months post-intervention]

  2. Berg Balance Scale [baseline, 3 months, 6 months, and 3 months post-intervention]

  3. Dynamic Gait Index [Baseline, 3 months, 6 months, and 3 months post intervention]

  4. Step Activity Monitoring [Baseline, 3 months, 6 months, and 3 months post-intervention]

  5. 6 Minute Walks [Baseline, 3 months, 6 months, and 3 months post-intervention]

Secondary Outcome Measures

  1. Psychosocial questionnaires [baseline, 3 months, 6 months, and 3 months post-intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Ischemic stroke greater than or equal to 6 months prior in men or women ages 40- or older. Hemorrhagic stroke greater than or equal to one year prior in men or women ages 40-or older.

  2. Residual hemiparetic gait deficits.

  3. Already completed all conventional inpatient and outpatient physical therapy.

  4. Adequate language and neurocognitive function to participate in exercise testing and training (specific screening instruments used.)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Baltimore VAMC Baltimore Maryland United States 21201

Sponsors and Collaborators

  • Baltimore VA Medical Center
  • University of Maryland

Investigators

  • Principal Investigator: Richard F Macko, MD, University of Maryland
  • Principal Investigator: Kathleen M Michael, PhD, University of Maryland
  • Principal Investigator: Andrew P Goldberg, MD, University of Maryland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01042990
Other Study ID Numbers:
  • HP-00040264
First Posted:
Jan 6, 2010
Last Update Posted:
Jan 6, 2010
Last Verified:
Dec 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 6, 2010